Literature DB >> 16871352

Pulmonary hypertension in a patient with adult-onset Stills disease.

Eisha Mubashir1, M Mubashir Ahmed, Samina Hayat, Maureen Heldmann, Seth Mark Berney.   

Abstract

Pulmonary manifestations of adult-onset Still's disease (AOSD) include aseptic pneumonitis, pleural effusions, rarely acute respiratory distress syndrome, and restrictive lung disease. Pulmonary arterial hypertension (PAH) occurs with several rheumatologic diseases, however, has only been reported once in AOSD. We describe a 29-year-old woman with a 9-year history of AOSD, who developed PAH without any other obvious cause. Therefore, we conclude that this is likely a result of pulmonary vascular changes related to AOSD.

Entities:  

Mesh:

Year:  2006        PMID: 16871352     DOI: 10.1007/s10067-006-0382-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

Authors:  C D Cool; J S Stewart; P Werahera; G J Miller; R L Williams; N F Voelkel; R M Tuder
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Treatment of pulmonary hypertension secondary to connective tissue diseases.

Authors:  O Sanchez; M Humbert; O Sitbon; G Simonneau
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 3.  Mixed connective tissue disease.

Authors:  R W Hoffman; E L Greidinger
Journal:  Curr Opin Rheumatol       Date:  2000-09       Impact factor: 5.006

4.  Primary and secondary pulmonary hypertension in systemic lupus erythematosus.

Authors:  T L Pan; J Thumboo; M L Boey
Journal:  Lupus       Date:  2000       Impact factor: 2.911

5.  Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.

Authors:  M Okawa-Takatsuji; S Aotsuka; M Fujinami; S Uwatoko; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

6.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

7.  Clinical and laboratory features of scleroderma patients with pulmonary hypertension.

Authors:  K Yamane; H Ihn; Y Asano; N Yazawa; M Kubo; K Kikuchi; Y Soma; K Tamaki
Journal:  Rheumatology (Oxford)       Date:  2000-11       Impact factor: 7.580

8.  Vascular smooth muscle cell phenotypes in primary pulmonary hypertension.

Authors:  Y Mitani; M Ueda; R Komatsu; K Maruyama; R Nagai; M Matsumura; M Sakurai
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

9.  Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

Authors:  M Humbert; G Monti; F Brenot; O Sitbon; A Portier; L Grangeot-Keros; P Duroux; P Galanaud; G Simonneau; D Emilie
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405

Review 10.  [Pulmonary hypertension complicating systemic diseases other than connective tissue diseases].

Authors:  O Sanchez; G Garcia; A Hamid; H Nunes; V Ioos; T H Razafy Andriamihoatra; F Parent; G Simonneau; M Humbert
Journal:  Presse Med       Date:  2003-05-17       Impact factor: 1.228

View more
  13 in total

1.  [Adult onset Still's disease].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

2.  An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.

Authors:  Mili V Mehta; Daniel K Manson; Evelyn M Horn; Jennifer Haythe
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.

Authors:  Yukiko Kimura; Jennifer E Weiss; Kathryn L Haroldson; Tzielan Lee; Marilynn Punaro; Sheila Oliveira; Egla Rabinovich; Meredith Riebschleger; Jordi Antón; Peter R Blier; Valeria Gerloni; Melissa M Hazen; Elizabeth Kessler; Karen Onel; Murray H Passo; Robert M Rennebohm; Carol A Wallace; Patricia Woo; Nico Wulffraat
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

4.  Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra.

Authors:  Marc Campos; Elena Schiopu
Journal:  Case Rep Rheumatol       Date:  2012-08-29

5.  Pulmonary arterial hypertension in adult onset Still's disease: a case report of a severe complication.

Authors:  L Guilleminault; S Laurent; A Foucher; P Poubeau; F Paganin
Journal:  BMC Pulm Med       Date:  2016-05-10       Impact factor: 3.317

6.  Pulmonary arterial hypertension secondary to adult-onset Still's disease: Response to cyclosporine and sildenafil over 15 years of follow-up.

Authors:  Jason Weatherald; Johan Lategan; Doug Helmersen
Journal:  Respir Med Case Rep       Date:  2016-06-20

Review 7.  Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review.

Authors:  Mathieu Gerfaud-Valentin; Vincent Cottin; Yvan Jamilloux; Arnaud Hot; Agathe Gaillard-Coadon; Isabelle Durieu; Christiane Broussolle; Jean Iwaz; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease.

Authors:  Grant H Lowther; Jason Chertoff; Jessica Cope; Hassan Alnuaimat; Ali Ataya
Journal:  Pulm Circ       Date:  2017-06-06       Impact factor: 3.017

Review 9.  Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature.

Authors:  Asami Masui-Ito; Ryuji Okamoto; Kaoru Ikejiri; Mika Fujimoto; Muneyoshi Tanimura; Shiro Nakamori; Tomohiro Murata; Eiji Ishikawa; Norikazu Yamada; Hiroshi Imai; Masaaki Ito
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 10.  Life-threatening complications of adult-onset Still's disease.

Authors:  Petros Efthimiou; Sabeeda Kadavath; Bella Mehta
Journal:  Clin Rheumatol       Date:  2014-01-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.